Interferon Alfacon-1 use while Breastfeeding
Drugs containing Interferon Alfacon-1: Infergen
Interferon Alfacon-1 Levels and Effects while Breastfeeding
Summary of Use during Lactation
There are no data on the use of interferon alfacon-1 during breastfeeding. However, the amount of the closely related drug, interferon alfa, excreted in milk is very low. Any interferon in breastmilk is probably destroyed in the infant's gastrointestinal tract and not absorbed, except perhaps in neonates.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
References
Interferon Alfacon-1 Identification
Substance Name
CAS Registry Number
118390-30-0
Drug Class
- Immunologic Adjuvants
Administrative Information
LactMed Record Number
581
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2010-12-07
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Interferon alfacon-1 use during Pregnancy
- Interferon Alfacon-1 Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
